Tholander B.; Koliadi A.; Botling J.; Dahlstrand H.; Von Heideman A.; Ahlström H.; Öberg K.; Ullenhag G. J. Complete Response With Combined BRAF and MEK Inhibition in BRAF Mutated Advanced Low-Grade Serous Ovarian Carcinoma. ujms 2020, 125, 325–329.